Evidence map›Paper›PMID 38830925›Full record

ArticleScientific reports2024

Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia.

Rosario Menéndez, Raúl Méndez, Paula González-Jiménez, Ana Latorre, Soledad Reyes, Rafael Zalacain, Luis A Ruiz, Leyre Serrano, Pedro P España, Ane Uranga and 6 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rosario Menéndez *Pneumology Department, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Raúl Méndez *Pneumology Department, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain. mendez_rau@gva.es.
Paula González-JiménezPneumology Department, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Ana LatorreRespiratory Infections, Health Research Institute La Fe (IISLAFE), Valencia, Spain.
Soledad ReyesPneumology Department, La Fe University and Polytechnic Hospital, Avda. Fernando Abril Martorell 106, 46026, Valencia, Spain.
Rafael ZalacainPneumology Department, Cruces University Hospital, Barakaldo, Spain.
Luis A RuizPneumology Department, Cruces University Hospital, Barakaldo, Spain.
Leyre SerranoPneumology Department, Cruces University Hospital, Barakaldo, Spain.
Pedro P EspañaPneumology Department, Galdakao-Usansolo Hospital, Galdacano, Spain.
Ane UrangaPneumology Department, Galdakao-Usansolo Hospital, Galdacano, Spain.
Catia CillónizCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Andrea Gaetano-GilClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Borja M Fernández-FélixClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
Luis Pérez-de-LlanoPneumology Department, Lucus Augusti University Hospital, Lugo, Spain.
Rafael GolpePneumology Department, Lucus Augusti University Hospital, Lugo, Spain.
Antoni TorresCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

Funding

Health Research Institute La Fe 2019-053-1Instituto de Salud Carlos III JR21/00051Instituto de Salud Carlos III PI17/01421Sociedad Española de Neumología y Cirugía Torácica 1078/2020Sociedad Española de Neumología y Cirugía Torácica Convocatoria extraordinaria PII Infecciones Respiratorias 2011
6 · The paper itself

Abstract

Improved phenotyping in pneumonia is necessary to strengthen risk assessment. Via a feasible and multidimensional approach with basic parameters, we aimed to evaluate the effect of host response at admission on severity stratification in COVID-19 and community-acquired pneumonia (CAP). Three COVID-19 and one CAP multicenter cohorts including hospitalized patients were recruited. Three easily available variables reflecting different pathophysiologic mechanisms-immune, inflammation, and respiratory-were selected (absolute lymphocyte count [ALC], C-reactive protein [CRP] and, SpO

Indexed as

Community-Acquired InfectionsCOVID-19Hospital MortalityAgedAged, 80 and overBiomarkersC-Reactive ProteinFemaleHumansIntensive Care UnitsLymphocyte CountMaleMiddle AgedPneumoniaRisk AssessmentSARS-CoV-2BiomarkersC-Reactive ProteinBiomarkersCOVID-19Host responseMortalityPneumonia

Identifiers

PMID38830925
PMCPMC11148180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.